Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Resolution of chronic synovitis with Emicizumab?
Emicizumab continues to reshape our understanding of joint outcomes in severe Hemophilia A — transforming not only bleeding prevention, but also long‑term joint health.
At EAHAD2026, this poster by Matteo Di Minno, using HEAD‑US and HJHS in 52 adults on long‑term Emicizumab prophylaxis showed:
- Significant improvement in hypertrophic synovium scores over ≥2 years
- >50% of joints with hypertrophic synovium at baseline showed reduction or resolution
- Very few de‑novo HS findings in previously unaffected joints, suggesting structural joint protection in routine practice
Interestingly, joints with pre‑existing degenerative changes improved the least – a strong reminder that timing of effective prophylaxis still matters.
It will be particularly interesting to see how these real‑world imaging data will align with the ongoing Phase IV Beyond ABR study (NCT05181618), which is exploring broader health and joint outcomes under Emicizumab.”
Find more posts featuring Wolfgang Miesbach on Hemostasis Today.
-
May 28, 2026, 12:57Ahmed Kardousha: Protecting Growth and Fertility in Transfusion-Dependent β-Thalassemia
-
May 28, 2026, 12:36Kabilan K L: Key Nursing Considerations for Abciximab Therapy
-
May 28, 2026, 12:17Astha Thakkar: Practical Approaches to Platelet Thresholds in ITP
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early
-
May 28, 2026, 09:15Alejandro González Veliz: Why Cardiovascular Prevention Matters More Than Intervention
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly